GlucoTrack, Inc. Files 8-K

Ticker: GCTK · Form: 8-K · Filed: Jul 8, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateJul 8, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, financial-exhibits

TL;DR

GlucoTrack filed an 8-K, expect updates soon.

AI Summary

GlucoTrack, Inc. filed an 8-K on July 8, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits.

Why It Matters

This 8-K filing indicates GlucoTrack, Inc. is making a regulatory disclosure and submitting financial exhibits, which could contain important updates for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant financial events or risks.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing does not specify the exact nature of the Regulation FD disclosure.

What financial statements and exhibits are included in this filing?

The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated July 8, 2024.

What is GlucoTrack, Inc.'s principal executive office address?

GlucoTrack, Inc.'s principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

What was GlucoTrack, Inc.'s former company name?

GlucoTrack, Inc.'s former company name was Integrity Applications, Inc.

Filing Stats: 474 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-07-08 16:30:16

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 8, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing